rethinkPeptides Search
Menu
RethinkPeptides

Research library — page 114

Browse more peptide research, methods and limitations.

Filter by topic, method, and evidence

You can select more than one topic or evidence level.

Clear filters

RPEP-13049 · 2025

Bariatric Surgery and Semaglutide Affect Bones and Heart Differently in Obese Mice

VSG and semaglutide produced comparable weight loss but had divergent effects on bone mineral density and cardiac function in obese mice.

Picoli, Caroline de Carvalho; Tsibulnikov, Sergey; Ho, Mavy; DeMambro, Victoria; Feng, Tiange; Eltahir, May; Le, Phuong T; Chlebek, Carolyn; Rosen, Clifford J; Ryzhov, Sergey; Li, Ziru · Animal Study

RPEP-13051 · 2025

Does Tirzepatide Affect the Body's Ability to Recover from Low Blood Sugar?

Tirzepatide 15 mg preserved counterregulatory hormone responses (including glucagon) during induced hypoglycemia, while lowering HbA1c by 1.5%.

Pieber, Thomas R; Svehlikova, Eva; Urva, Shweta; Haupt, Axel; Zhou, Chunmei; Coskun, Tamer; Höller, Vera; Fluhr, Gabriele; Karanikas, Chrisanthi A; Milicevic, Zvonko; Pratt, Edward John · Randomized Controlled Trial

RPEP-13055 · 2025

Semaglutide: A Comprehensive Look at Both the Benefits and the Risks

Semaglutide provides multi-system benefits (glycemic control, weight loss, cardiovascular protection, potential neuroprotection) but carries risks including pancreatitis and anesthetic complications.

Pillarisetti, Lekha; Agrawal, Devendra K · Narrative Review

RPEP-13056 · 2025

Can GLP-1 Drugs Slow Down Alzheimer's and Parkinson's Disease?

Human clinical trials show early promise for GLP-1 receptor agonists in neurodegenerative diseases, supported by strong preclinical evidence of neuroprotection.

Pilśniak, Joanna; Węgrzynek-Gallina, Julia; Bednarczyk, Błażej; Buczek, Aleksandra; Pilśniak, Aleksandra; Chmiela, Tomasz; Jarosińska, Agnieszka; Siuda, Joanna; Holecki, Michał · Narrative Review

RPEP-13057 · 2025

Snake Venom Toxin Uses Immune Receptors for Signaling but Not for Cell Entry

Formyl peptide receptors mediate crotoxin's immunomodulatory effects on macrophages but are not involved in its cellular entry mechanism.

Pimenta, Luciana de Araújo; Kato, Ellen Emi; Sobral, Ana Claudia Martins; Duarte, Evandro Luiz; Lamy, Maria Teresa Moura; Pasqualoto, Kerly Fernanda Mesquita; Sampaio, Sandra Coccuzzo · In Vitro

RPEP-13060 · 2025

Fermented Sheep Milk Produces Peptides That May Fight Diabetes and High Blood Pressure

Fermented sheep whey peptides showed 67-72% inhibition of diabetes and blood pressure-related enzymes, with molecular dynamics confirming stable target binding.

Pipaliya, Rinkal; Basaiawmoit, Bethsheba; Sakure, Amar A; Maurya, Ruchika; Bishnoi, Mahendra; Kondepudi, Kanthi Kiran; Tiwary, Bipransh Kumar; Mankad, Maunil; Patil, G B; Gawai, Kunal; Sarkar, Preetam; Hati, Subrota · In Vitro

RPEP-13062 · 2025

Migraine Antibodies May Also Help With Chemotherapy-Induced Appetite Loss and Weight Loss

Systemically administered anti-CGRP migraine antibodies reached the brain and counteracted food aversion memories and chemotherapy-induced weight loss in rats.

Pistolesi, Alessandra; Tuniz, Simone; Luceri, Cristina; Molli, Alice; Urru, Matteo; La Rocca, Antonino Iurato; Tanturli, Michele; De Cesaris, Francesco; Buonvicino, Daniela; Chiarugi, Alberto · Animal Study

RPEP-13064 · 2025

Steroids Increase CGRP Levels in Migraine Nerve Tissue — But Don't Cause Pain

Corticosteroids upregulated CGRP and receptor expression in the trigeminal system but did not induce head pain, challenging simple CGRP-pain assumptions.

Pistolesi, Alessandra; Tuniz, Simone; Lapucci, Andrea; Molli, Alice; De Cesaris, Francesco; Landini, Lorenzo; Nassini, Romina; Buonvicino, Daniela; Chiarugi, Alberto · Animal Study

RPEP-13066 · 2025

Semaglutide May Reduce Anxiety and Depression by Calming Brain Inflammation

Semaglutide reduced anxiety and depression in diabetic animal models by modulating the kynurenine pathway and neurobiological markers in the prefrontal cortex.

Piątkowska-Chmiel, Iwona; Wicha-Komsta, Katarzyna; Pawłowski, Kamil; Syrytczyk, Aleksandra; Kocki, Tomasz; Dudka, Jarosław; Herbet, Mariola · Animal Study

RPEP-13067 · 2025

What Reddit Users Say About Their Weight Loss Experience on Wegovy

Qualitative analysis of 660 Reddit posts provides rich patient narratives about real-world semaglutide 2.4 mg experiences during a period of high demand and shortages.

Plenn, Eion; Amin, Dylan; Henry, Jonathan; Leavitt, Gabrielle; Walker, Jason; Soleymani, Taraneh · Qualitative

RPEP-13068 · 2025

Who Actually Starts Semaglutide for Weight Loss? A Claims Data Analysis

Identified demographic and clinical factors associated with semaglutide initiation for obesity in commercially insured adults without diabetes.

Podolsky, Meghan I; Raquib, Rafeya; Shafer, Paul R; Hempstead, Katherine; Ellis, Randall P; Stokes, Andrew C · Retrospective Cohort

RPEP-13072 · 2025

How Kidney Disease Worsens Heart Attack Outcomes Through Hormonal Imbalances

Reduced kidney function in heart attack patients is associated with elevated RAAS biomarkers and endothelial dysfunction markers that worsen cardiovascular outcomes.

Polianska, Oksana; Tashchuk, Victor; Hulaha, Olha; Olinchuk, Valentyna; Moskaliuk, Inna; Kushnir, Yevhen · Observational

RPEP-13073 · 2025

Ghrelin is far more than a hunger hormone—it regulates immunity, brain health, cardiovascular function, and bone

Ghrelin acts as a pleiotropic regulator across feeding, GH release, glucose homeostasis, cardiovascular tone, bone remodeling, immunity, neuroprotection, and addiction. Cryo-EM structures reveal bipartite GHSR1a binding pocket enabling biased signaling. Des-acyl ghrelin and mini-ghrelins have distinct, context-dependent effects. LEAP-2 and GOAT inhibitors are emerging therapeutic strategies.

Polishchuk, Hlafira; Guzik, Krzysztof; Kantyka, Tomasz · Narrative Review

RPEP-13074 · 2025

Does Taking GLP-1 Drugs Before Bariatric Surgery Affect Long-Term Outcomes?

Propensity-matched analysis evaluated whether preoperative GLP-1 use affects bariatric surgery outcomes over three years.

Poljo, Adisa; Reichl, Jakob J; Bürgi, Simon; Dirnberger, Amanda S; Schneider, Romano; Klasen, Jennifer M; Billeter, Adrian T; Müller, Beat P; Peterli, Ralph; Kraljević, Marko · Observational

RPEP-13079 · 2025

How GLP-1 Drugs Affect What People with Diabetes Actually Eat

GLP-1 RA users showed differences in dietary intake and Mediterranean diet adherence compared to patients on other diabetes medications.

Ponzo, Valentina; Vitale, Marilena; Bo, Simona; Broglio, Fabio; Goitre, Ilaria; Cioffi, Iolanda · Observational

RPEP-13081 · 2025

How GLP-1 Drugs May Shrink Dangerous Fat Around the Heart

GLP-1 and dual GIP/GLP-1 agonists reduce epicardial adipose tissue volume and inflammatory activity, providing a distinct cardiovascular protection mechanism.

Pop, Andrea S K; Dănilă, Maria D; Giuchici, Silvia; Buriman, Darius G; Lolescu, Bogdan M; Sturza, Adrian; Muntean, Danina M; Lascu, Ana · Narrative Review

RPEP-13082 · 2025

Do Different Diabetes Drugs Affect Heart Rhythm and Nerve Function Differently? The GRADE Trial

Different glucose-lowering drugs showed varying effects on ECG abnormalities and cardiac autonomic neuropathy prevalence over 4 years in the GRADE trial.

Pop-Busui, Rodica; Rosin, Samuel P; Butera, Nicole M; Krause-Steinrauf, Heidi; Abou Assi, Hiba; Garg, Rajesh K; Inzucchi, Silvio E; Katona, Aimee; McGill, Janet B; Mudaliar, Sunder; Schade, David S; Seaquist, Elizabeth R; Tiktin, Margaret; Soliman, Elsayed Z; Green, Jennifer B · Rct

RPEP-13084 · 2025

Designer Amino Acids Create Smarter Drug-Delivery Hydrogels

Noncanonical amino acids in peptide hydrogels modulate physicochemical properties, enhancing stability, biocompatibility, and functionality for biomedical use.

Pophali, Salil; Shrivastava, Vidit; Misra, Rajkumar; Jain, Rahul · Narrative Review

RPEP-13087 · 2025

Real-World Results of GLP-1 Drugs for Overweight Diabetes Patients in Romania

All GLP-1 RAs studied improved HbA1c, body weight, and waist circumference in real-world Romanian clinical practice.

Popoviciu, Mihaela Simona; Reurean-Pintilei, Delia; Salmen, Teodor; Rus, Marius; Ferician, Anca; Sava, Cristian; Ardelean, Adriana Ioana; Moroianu, Lavinia-Alexandra; Pantea Stoian, Anca · Observational

RPEP-13089 · 2025

How the Body's Natural Defense Peptides Block Gene Therapy Viruses

HD5 prevents AAV cell binding while HNP1 neutralizes AAV post-binding — two distinct innate immune mechanisms that limit gene therapy efficacy.

Porter, Jessica M; Hulce, Kaitlin R; Oswald, Mackenzi S; Busuttil, Kevin; Emmanuel, Shanan N; Bennett, Antonette; McKenna, Robert; Smith, Jason G · Laboratory

RPEP-13090 · 2025

Alpha-defensin peptides block gene therapy vectors by preventing them from reaching the cell nucleus

HD5 prevents AAV2/AAV6 cell binding; both HD5 and HNP1 inhibit VP1 unique domain externalization required for endosome escape and nuclear entry; both defensins prevent AAV from reaching the nucleus. This mechanism parallels how defensins neutralize other non-enveloped viruses.

Porter, Jessica M; Hulce, Kaitlin R; Oswald, Mackenzi S; Busuttil, Kevin; Emmanuel, Shanan N; Bennett, Antonette; McKenna, Robert; Smith, Jason G · Laboratory

RPEP-13091 · 2025

How GLP-1 Drug Dulaglutide Slows Stomach Emptying and Affects Other Medications

A combined PopPK/PBPK model accurately predicts how dulaglutide-induced gastric emptying delay affects oral drug absorption and pharmacokinetics.

Posada, Maria M; Schneck, Karen B; Morse, Bridget L; Rougee, Luc R A; Tham, Lai San; Rehmel, Jessica F; Thompson, Brian; Stamatis, Stephen D; Hall, Stephen D; Dickinson, Gemma L · Computational

RPEP-13094 · 2025

Radioactive Peptide Therapy for Neuroendocrine Cancer That Has Spread to the Abdomen

PRRT showed limited response in peritoneal/mesenteric neuroendocrine disease (stable volumes) despite responses in liver metastases, with digestive complication risks.

Poterszman, Nathan; Baltzinger, Philippe; Mamulashvili Bessac, Darejan; Pham Van, Floriane; Goichot, Bernard; Mertz, Luc; Addeo, Pietro; Brigand, Cecile; Imperiale, Alessio · Observational

RPEP-13095 · 2025

Can GLP-1 Drugs Reduce Inflammation Linked to Knee Osteoarthritis in Overweight Patients?

Study evaluated whether diet-induced weight loss and subsequent liraglutide treatment reduce NGAL, a proinflammatory biomarker linked to osteoarthritis.

Poulsen, Asbjørn Seenithamby; Stisen, Zara Rebecca; Skougaard, Marie; Christensen, Robin; Overgaard, Anders; Gudbergsen, Henrik; Jacobsen, Stine; Balslev-Clausen, Andreas Peter; Henriksen, Marius; Kristensen, Lars Erik; Bliddal, Henning · Rct